Valtension comp. 160+12,5 mg filmovertrukne tabletter Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

valtension comp. 160+12,5 mg filmovertrukne tabletter

teva b.v. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+12,5 mg

Valteva comp. 160+12,5 mg filmovertrukne tabletter Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

valteva comp. 160+12,5 mg filmovertrukne tabletter

teva b.v. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+12,5 mg

Ketorolac trometamol "S.A.L.F." 30 mg/ml injektionsvæske, opløsning Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

ketorolac trometamol "s.a.l.f." 30 mg/ml injektionsvæske, opløsning

s.a.l.f. s.p.a. - ketorolactrometamol - injektionsvæske, opløsning - 30 mg/ml

Azacare 50 mg filmovertrukne tabletter Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

azacare 50 mg filmovertrukne tabletter

2care4 aps - azathioprin - filmovertrukne tabletter - 50 mg

Amikacin "Macure" 250 mg/ml injektionsvæske, opløsning Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

amikacin "macure" 250 mg/ml injektionsvæske, opløsning

macure pharma aps - amikacinsulfat - injektionsvæske, opløsning - 250 mg/ml

Dovprela (previously Pretomanid FGK) Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - tuberkulose, multidrugt-resistent - antimyco-bakterielle midler - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Teriflunomide Mylan Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide "Sandoz" 14 mg filmovertrukne tabletter Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

teriflunomide "sandoz" 14 mg filmovertrukne tabletter

sandoz a/s - teriflunomid - filmovertrukne tabletter - 14 mg

Qaialdo Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolacton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.